Literature DB >> 22767438

Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.

Zhao-Lin Zeng1, Fu-Jun Li, Feng Gao, Dong-Sheng Sun, Lei Yao.   

Abstract

BACKGROUND: In the last decade, studies in hepatocellular carcinoma (HCC) demonstrate dysregulation of miRNAs expression. For instance, miR-650 has been implicated in gastric and colorectal cancer tumorigenicity; however, the role of miR-650 remains unknown in HCC.
METHODS: In this study, we performed a comprehensive analysis to examine the miR-650 expression level in 248 HCC and 120 paracarcinomatous liver (PCL) tissues. The correlations between miR-650 expression level and the clinicopathological characteristics (HCC tumorigenicity) were evaluated. The role of miR-650 played in HCC was investigated by Q-PCR, western blot, and MTT.
RESULTS: We found that miR-650 expression was significantly increased in HCC patients and significantly associated with the patients' age (P = 0.0019), differentiation capability (P = 0.0108), and also tumor stage (P = 0.0069). Moreover, we compared the expression level of both ING4 and miR-650 in 122 HCC patients by western blot and real-time PCR. Statistical result showed a significant negative correlation between them (r(s)  = -0.2011, P = 0.0264). Transfection and MTT test suggested that miR-650 decreased the expression of ING4 and stimulate liver cells proliferation significantly.
CONCLUSION: These data suggested that miR-650 is correlated with the pathogenesis of HCC and is involved in the HCC tumorigenesis process by inhibiting the expression of ING4.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767438     DOI: 10.1002/jso.23210

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  27 in total

1.  miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.

Authors:  Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Paola Lucia Chiara Iervolino; Esther Imperlini; Annalisa Mandola; Anna Verde; Anna Elisa De Stefano; Katia Pane; Monica Franzese; Silvia Esposito; Fulvio Basolo; Stefania Orrù; Giuliana Salvatore
Journal:  Endocrine       Date:  2019-03-29       Impact factor: 3.633

2.  Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.

Authors:  Shijie Li; Tianli Fan; Hongtao Liu; Jiangtao Chen; Changjiang Qin; Xuequn Ren
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

3.  Essential role of microRNA-650 in the regulation of B-cell CLL/lymphoma 11B gene expression following transplantation: A novel mechanism behind the acute rejection of renal allografts.

Authors:  Peng Jin; Hongxi Chen; Jinliang Xie; Cheng Zhou; Xiangrong Zhu
Journal:  Int J Mol Med       Date:  2017-10-17       Impact factor: 4.101

4.  Recombinant ING4 suppresses the migration of SW579 thyroid cancer cells via epithelial to mesenchymal transition.

Authors:  Chuan-Jiang Wang; Dong Yang; Ying-Wei Luo
Journal:  Exp Ther Med       Date:  2015-05-22       Impact factor: 2.447

5.  MicroRNA-650 in a copy number-variable region regulates the production of interleukin 6 in human osteosarcoma cells.

Authors:  Jun Ho Yun; Sanghoon Moon; Heun-Sik Lee; Mi Yeong Hwang; Yeon-Jung Kim; Ho-Yeong Yu; Youngsoo Kim; Bok-Ghee Han; Bong-Jo Kim; Jeong-Min Kim
Journal:  Oncol Lett       Date:  2015-08-07       Impact factor: 2.967

6.  Remifentanil reduces the proliferation, migration and invasion of HCC cells via lncRNA NBR2/miR-650/TIMP3 axis.

Authors:  Wei Liang; Jinyuan Ke
Journal:  Int J Exp Pathol       Date:  2022-02-13       Impact factor: 1.925

Review 7.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

8.  MicroRNA-650 expression in glioma is associated with prognosis of patients.

Authors:  Boqian Sun; Bo Pu; Dake Chu; Xiaodan Chu; Wei Li; Dun Wei
Journal:  J Neurooncol       Date:  2013-09-24       Impact factor: 4.130

9.  Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression.

Authors:  Ze-Hua Zuo; Yan P Yu; Ying Ding; Silvia Liu; Amantha Martin; George Tseng; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2015-05-05       Impact factor: 4.307

10.  microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.

Authors:  Ying Ye; Juhua Zhuang; Guoyu Wang; Saifei He; Jing Ni; Wei Xia; Jiening Wang
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.